Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    CONMED Corporation

    NYSE: CNMD · Real-Time Price · USD
    53.36
    -0.19 (-0.35%)
    At close: Jun 16, 2025, 3:59 PM
    53.38
    0.04%
    After-hours: Jun 16, 2025, 06:00 PM EDT

    CONMED Statistics

    Share Statistics

    CONMED has 30.94M shares outstanding. The number of shares has increased by 0.35% in one year.

    Shares Outstanding

    n/a
    		 30.94M

    Shares Change (YoY)

    n/a
    		 0.35%

    Shares Change (QoQ)

    n/a
    		 0.06%

    Owned by Institutions (%)

    n/a
    		 99.99%

    Shares Floating

    n/a
    		 30.07M

    Failed to Deliver (FTD) Shares

    n/a
    		 9,113

    FTD / Avg. Volume

    n/a
    		 2.03%

    Short Selling Information

    The latest short interest is 2.61M, so 8.45% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 2.61M

    Short % of Shares Out

    n/a
    		 8.45%

    Short % of Float

    n/a
    		 11.71%

    Short Ratio (days to cover)

    n/a
    		 8.84

    Valuation Ratios

    The PE ratio is 15.94 and the forward PE ratio is 11.34. CONMED's PEG ratio is 0.15.

    PE Ratio

    n/a
    		 15.94

    Forward PE

    n/a
    		 11.34

    PS Ratio

    n/a
    		 1.62

    Forward PS

    n/a
    		 1.1

    PB Ratio

    n/a
    		 2.19

    P/FCF Ratio

    n/a
    		 13.72

    PEG Ratio

    n/a
    		 0.15
    Financial Ratio History

    Enterprise Valuation

    CONMED has an Enterprise Value (EV) of 2.99B.

    EV / Sales

    n/a
    		 2.29

    EV / EBITDA

    n/a
    		 11.89

    EV / EBIT

    n/a
    		 17.92

    EV / FCF

    n/a
    		 19.45

    Financial Position

    The company has a current ratio of 2.3, with a Debt / Equity ratio of 0.94.

    Current Ratio

    n/a
    		 2.3

    Quick Ratio

    n/a
    		 1.05

    Debt / Equity

    n/a
    		 0.94

    Debt / EBITDA

    n/a
    		 3.6

    Debt / FCF

    n/a
    		 5.89

    Interest Coverage

    n/a
    		 5.37

    Financial Efficiency

    Return on Equity is 13.76% and Return on Invested Capital is 8.02%.

    Return on Equity

    n/a
    		 13.76%

    Return on Assets

    n/a
    		 5.74%

    Return on Invested Capital

    n/a
    		 8.02%

    Revenue Per Employee

    n/a
    		 $335,132.05

    Profits Per Employee

    n/a
    		 $33,954.62

    Employee Count

    n/a
    		 3,900

    Asset Turnover

    n/a
    		 0.57

    Inventory Turnover

    n/a
    		 1.66

    Taxes

    Income Tax

    n/a
    		 30.61M

    Effective Tax Rate

    n/a
    		 18.77%

    Stock Price Statistics

    The stock price has increased by -24.18% in the last 52 weeks. The beta is 1.24, so CONMED's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.24

    52-Week Price Change

    n/a
    		 -24.18%

    50-Day Moving Average

    n/a
    		 55.09

    200-Day Moving Average

    n/a
    		 64.8

    Relative Strength Index (RSI)

    n/a
    		 39.91

    Average Volume (20 Days)

    n/a
    		 449,607

    Income Statement

    In the last 12 months, CONMED had revenue of 1.31B and earned 132.42M in profits. Earnings per share was 4.29.

    Revenue

    n/a
    		 1.31B

    Gross Profit

    n/a
    		 733.03M

    Operating Income

    n/a
    		 200.33M

    Net Income

    n/a
    		 132.42M

    EBITDA

    n/a
    		 251.63M

    EBIT

    n/a
    		 200.33M

    Earnings Per Share (EPS)

    n/a
    		 4.29
    Full Income Statement

    Balance Sheet

    The company has 24.46M in cash and 905.78M in debt, giving a net cash position of -881.32M.

    Cash & Cash Equivalents

    n/a
    		 24.46M

    Total Debt

    n/a
    		 905.78M

    Net Cash

    n/a
    		 -881.32M

    Retained Earnings

    n/a
    		 560.28M

    Total Assets

    n/a
    		 2.3B

    Working Capital

    n/a
    		 355.85M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 166.97M and capital expenditures -13.08M, giving a free cash flow of 153.88M.

    Operating Cash Flow

    n/a
    		 166.97M

    Capital Expenditures

    n/a
    		 -13.08M

    Free Cash Flow

    n/a
    		 153.88M

    FCF Per Share

    n/a
    		 4.99
    Full Cash Flow Statement

    Margins

    Gross margin is 56.08%, with operating and profit margins of 15.33% and 10.13%.

    Gross Margin

    n/a
    		 56.08%

    Operating Margin

    n/a
    		 15.33%

    Pretax Margin

    n/a
    		 12.47%

    Profit Margin

    n/a
    		 10.13%

    EBITDA Margin

    n/a
    		 19.25%

    EBIT Margin

    n/a
    		 15.33%

    FCF Margin

    n/a
    		 11.77%

    Dividends & Yields

    CNMD pays an annual dividend of $1, which amounts to a dividend yield of 1.49%.

    Dividend Per Share

    n/a
    		 $1.00

    Dividend Yield

    n/a
    		 1.49%

    Dividend Growth (YoY)

    n/a
    		 0%

    Payout Ratio

    n/a
    		 26.25%

    Earnings Yield

    n/a
    		 6.27%

    FCF Yield

    n/a
    		 7.29%
    Dividend Details

    Analyst Forecast

    The average price target for CNMD is $57.5, which is 7.8% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $57.5

    Price Target Difference

    n/a
    		 7.8%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 5
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 $107.25

    Lynch Upside

    n/a
    		 100.99%

    Graham Number

    n/a
    		 54.91

    Graham Upside

    n/a
    		 2.9%

    Stock Splits

    The last stock split was on Sep 10, 2001. It was a forward split with a ratio of 3:2.

    Last Split Date

    n/a
    		 Sep 10, 2001

    Split Type

    n/a
    		 forward

    Split Ratio

    n/a
    		 3:2

    Scores

    Altman Z-Score

    n/a
    		 2.17

    Piotroski F-Score

    n/a
    		 8

    Add to Watchlist